Crinetics Pharmaceuticals CRNX Product revenue, net — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's product revenue, net — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's product revenue, net — total revenue?
- Crinetics Pharmaceuticals (CRNX) reported product revenue, net — total revenue of $10.31M in Q1 2026.
- What does product revenue, net — total revenue mean?
- This metric represents the net revenue generated specifically from the sale of pharmaceutical products, excluding income from licensing, collaborations, or research grants. It serves as a primary indicator of the company's transition from a clinical-stage research entity to a commercial-stage enterprise. Tracking this figure helps investors evaluate the market adoption and commercial viability of the company's therapeutic portfolio.